Executive Function Deficits in Children with Attention-Deficit/Hyperactivity Disorder and Improvement with Lisdexamfetamine Dimesylate in an Open-Label Study

OBJECTIVE: To assess the effects of lisdexamfetamine dimesylate (LDX) on executive function (EF) behaviors in children with attention-deficit/hyperactivity disorder (ADHD). METHODS: This observational, open-label, 7-week, dose-optimization study of LDX (20–70 mg/day) in children with ADHD evaluated...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Turgay, Atilla, Ginsberg, Lawrence, Sarkis, Elias, Jain, Rakesh, Adeyi, Ben, Gao, Joseph, Dirks, Bryan, Babcock, Thomas, Scheckner, Brian, Richards, Cynthia, Lasser, Robert, Findling, Robert L.
Format: Artigo
Jezik:Inglês
Izdano: Mary Ann Liebert, Inc. 2010
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3005278/
https://ncbi.nlm.nih.gov/pubmed/21186969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cap.2009.0110
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items